Document is current
Any future updates will be listed below
-
Authors
Hines, Rochelle M. https://orcid.org/0000-0002-0459-7911
Maric, Hans Michael https://orcid.org/0000-0002-2719-4752
Hines, Dustin J.
Modgil, Amit
Panzanelli, Patrizia
Nakamura, Yasuko
Nathanson, Anna J.
Cross, Alan
Deeb, Tarek
Brandon, Nicholas J.
Davies, Paul
Fritschy, Jean-Marc https://orcid.org/0000-0002-8552-3702
Schindelin, Hermann https://orcid.org/0000-0002-2067-3187
Moss, Stephen J.
-
Funding
Funding for this research was provided by:
Canadian Institutes for Health Research Postdoctoral Fellowship
German Excellence Initiative Fellowship
Heart and Stroke Foundation of Canada (Fellowship)
Deutsche Forschungsgemeinschaft (FZ 82, SFB 487 C7, SCHI 425/8-1)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NS101888, NS081735, NS087662)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (MH097446, MH106954)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (DA037170)
- License Information
-
More Information
Article History
Received: 4 December 2017
Accepted: 5 July 2018
First Online: 7 August 2018
Change Date: 5 September 2018
Change Type: Update
Change Details: This Article was originally published without the accompanying Peer Review File. This file is now available in the HTML version of the Article; the PDF was correct from the time of publication.
Competing interests
: S.J.M. serves as a consultant for SAGE Therapeutics and AstraZeneca, relationships that are regulated by Tufts University. The remaining authors declare no competing interests.
